Sinkovic Andreja, Marinsek Martin, Svensek Franc
Department of Medical Intensive Care, General Hospital Maribor, Ljubljanska ulica 5, 2000 Maribor, Slovenia.
Wien Klin Wochenschr. 2006;118 Suppl 2:52-7. doi: 10.1007/s00508-006-0553-x.
In unstable angina and/or non-ST-elevation myocardial infarction (UA/NSTEMI), sex-related differences in outcomes are less well known than in ST-elevation myocardial infarction (STEMI), where women experience worse outcomes than men. Our aim was a prospective comparison between men and women with UA/NSTEMI of baseline characteristics, in-hospital complications, mortality, reinfarctions and combined endpoint of mortality and/or reinfarction during hospital stay, at 30 days and at six months.
Initial medical treatment was given to 92 men and 47 women with UA/NSTEMI. Percutaneous coronary interventions (PCI) were performed within the first 48 hours in cases of recurrent chest pain and/or rhythmic and/or hemodynamic instability.
Women were significantly older (66.6 +/- 9.6 vs. 59.7 +/- 10.6, P = 0.0001), less physically active (76.6% vs. 91.3%, P = 0.035), with significantly more frequent arterial hypertension (78.7% vs. 51%, P = 0.0039) and insulin-treated diabetes (17% vs. 5.4%, P = 0.0341), but with less likely prior MI (21.3% vs. 48.9%, P = 0.003), smoking (10.6% vs. 32.6%, P = 0.009) and dyslipidemia with HDL-cholesterol < 1.0 mmol/L (25.5% vs. 46.4%, P = 0.015) than men. Though medical and invasive treatments were similar in both sexes, women were at significantly increased risk of in-hospital pulmonary edema (OR 4.16, 95% CI 1.51 to 11.45) but not at increased risk of adverse in-hospital, 30-day and six-month outcomes in comparison with men.
Women with UA/NSTEMI, being significantly older and with more comorbidity, were at significantly increased risk of in-hospital heart failure but not at increased risk of in-hospital, 30-day and six-month adverse outcomes when compared with men, despite their similar treatments.
在不稳定型心绞痛和/或非ST段抬高型心肌梗死(UA/NSTEMI)中,与ST段抬高型心肌梗死(STEMI)相比,结局方面的性别差异鲜为人知,在STEMI中女性的结局比男性更差。我们的目的是对患有UA/NSTEMI的男性和女性在基线特征、住院并发症、死亡率、再梗死以及住院期间、30天和6个月时死亡率和/或再梗死的联合终点方面进行前瞻性比较。
对92名男性和47名女性UA/NSTEMI患者进行了初始药物治疗。对于复发性胸痛和/或节律和/或血流动力学不稳定的患者,在最初48小时内进行了经皮冠状动脉介入治疗(PCI)。
女性年龄显著更大(66.6±9.6岁对59.7±10.6岁,P = 0.0001),身体活动较少(76.6%对91.3%,P = 0.035),动脉高血压更频繁(78.7%对51%,P = 0.0039),接受胰岛素治疗的糖尿病更多(17%对5.4%,P = 0.0341),但既往心肌梗死的可能性较小(21.3%对48.9%,P = 0.003),吸烟较少(10.6%对32.6%,P = 0.009),高密度脂蛋白胆固醇<1.0 mmol/L的血脂异常较少(25.5%对46.4%,P = 0.015)。尽管两性的药物和侵入性治疗相似,但女性住院期间发生肺水肿的风险显著增加(比值比4.16,95%可信区间1.51至11.45),但与男性相比,住院期间、30天和6个月时不良结局的风险并未增加。
患有UA/NSTEMI的女性年龄显著更大,合并症更多,住院期间发生心力衰竭的风险显著增加,但与男性相比,尽管治疗相似,住院期间、30天和6个月时不良结局的风险并未增加。